European Inspections Present New Challenges to U.S. Manufacturers
This article was originally published in The Gold Sheet
Executive Summary
DANGEROUS CONVERSATIONS are at the heart of a European inspections process that fundamentally differs from FDA’s approach. There is little guidance about the process, which is geared toward reaching conclusions rather than building a case. The European Union inspectors are more experienced, less by-the-book, more likely to chat with workers on the shop floor, experts say. Their inspections tend to be quicker, and can vary by their country of origin
You may also be interested in...
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
How US FDA Will Unleash Attack On COVID-19 Variants Once Global Consensus Is Reached
Agency outlines plans to authorize variant COVID-19 vaccines and therapeutics based on swift quality assessments.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: